| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.02 | 0.8 |